Research shows many individuals with actionable genomic variants meet criteria for cancer testing but remain untested, highlighting gaps in genetic screening practices.
New research has uncovered a significant gap in genetic testing for people who may be at risk for hereditary cancer, including those with albinism who undergo genetic testing for multiple health reasons.
According to findings published in the American Journal of Human Genetics, the likelihood that individuals with medically actionable secondary genomic variants were affected with hereditary cancer ranged from 26.2% to 100%. Perhaps most concerning, researchers found that over half (51%) of these individuals actually met the diagnostic criteria for testing, suggesting considerable underuse of genetic screening.
This is particularly relevant for the albinism community, as genetic testing is often conducted for albinism diagnosis, but may reveal secondary findings related to other health conditions, including cancer predisposition.
Implications for Genetic Counseling
The study highlights how assessing the diagnostic yield and utility of secondary findings is crucial to inform policy development for population genomic screening. For people with albinism who undergo genetic testing, these findings underscore the importance of comprehensive genetic counseling that addresses all potential findings, not just those related to albinism.
As genetic testing becomes more common and comprehensive, healthcare providers serving the albinism community may need additional training to properly interpret and communicate these secondary findings to patients.
This research contributes to the growing conversation about how genetic testing protocols might be optimized to better serve all populations, ensuring that actionable health information doesn't go unnoticed or unaddressed.
Keywords
Core topics and entities mentioned in this summary.